Dr. Julius Torres Kellinghusen, DrPH, MPH, is a Public Health Professor at the College for Community Health, Montclair State University, and also affiliated with the NYU School of Global Public Health. His work focuses on community health practice, public health education, and advancing health equity. Dr. Kellinghusen is engaged in teaching, research, and service that emphasizes community-engaged approaches to improving population health outcomes. He is based in New York, United States.

Dr. Anand Srivastava is the Chairman and Founder of the Global Institute of Stem Cell Therapy and Research (GIOSTAR), headquartered in San Diego, California, USA. A distinguished scientist and visionary leader in the field of stem cell research and regenerative medicine, Dr. Srivastava has over 30 years of experience in molecular biology, human embryonic stem cell research, and translational therapeutics. His pioneering work has been instrumental in advancing the development of stem cell–based therapies for the treatment of various degenerative and genetic disorders. Under his leadership, GIOSTAR has established cutting-edge research and clinical centers across the globe, dedicated to delivering innovative and ethical regenerative medicine solutions. Dr. Srivastava has authored numerous scientific publications and serves as an advocate for integrating stem cell science into mainstream medical practice. His contributions continue to shape the global landscape of regenerative medicine, bridging the gap between scientific innovation and patient care.

Pamela Rowe, MA, CCC-SLP, is a highly accomplished Speech-Language Pathologist and Public Health Consultant with extensive experience in clinical leadership, healthcare innovation, and professional education. As the CEO and Clinical Director of a leading speech-language pathology practice, she has dedicated her career to advancing communication sciences, improving access to care, and promoting health equity across diverse populations. An engaging international keynote speaker and moderator, Pamela has led workshops and seminars on topics ranging from communication disorders and early intervention to healthcare leadership and public health policy. She also serves as a Grant and RFP Reviewer, contributing her expertise to programs that enhance healthcare delivery and community well-being. Currently pursuing dual graduate degrees in Doctor of Health Science (DHSc) and Master of Public Health (MPH), Pamela continues to integrate clinical excellence with evidence-based public health strategies. Her multidisciplinary perspective, leadership experience, and passion for empowering communities make her a respected voice in both clinical and public health spheres.

Zeinab (Eva) Deris Zayeri is a biomedical researcher with a Master’s degree in Human Genetics from Utrecht University in the Netherlands, where she is currently a guest researcher in the Department of Biology. With a strong background in biomedical sciences and bioinformatics, her work bridges molecular biology and computational genomics. Over the past decade, she has gained extensive experience in academic research, diagnostic laboratories, and hospitals, including at the Netherlands Cancer Institute. Her expertise spans next-generation sequencing (NGS), metagenomics, molecular genetics, epigenetics, and data-driven disease research, particularly in cancer, inflammation, and metabolic reprogramming. Zeinab has co-authored multiple peer-reviewed publications on topics such as neuroinflammation in COVID-19, the genetic basis of cardiovascular disease in diabetes, and epigenetic biomarkers in colorectal cancer. Combining wet-lab precision with computational insight, she is dedicated to advancing human genetics and biomedical science through integrative, data-driven research and scientific writing.

Dr. Yolanda Cabello is a leading professional in assisted reproduction, working as a Senior Clinical Embryologist, Scientific and Quality Consultant, and Professor. With over 20 years of experience, she holds a Ph.D. in Basic Medical Sciences, degrees in Biology and Psychology, and various Master's degrees. Currently affiliated with the IVF LIFE - CARE FERTILITY Group and serving as a Lead Auditor for GlobalGROUP, her career spans laboratory management, scientific directorship, and extensive research on sperm selection and pregnancy outcomes. Dr. Cabello is a recognized international speaker and an active contributor to professional societies and national health guidelines. Dr. Yolanda Cabello is a leading expert in assisted reproduction, combining over 20 years of experience as a Senior Clinical Embryologist, scientific consultant, and psychologist. She holds a Ph.D. in Basic Medical Sciences and currently serves with the IVF LIFE - CARE FERTILITY Group and as a Lead Auditor for GlobalGROUP. An active researcher, professor at the International University of Valencia, and international speaker, Dr. Cabello has published extensively and plays a key role in developing lab guidelines for the Spanish Ministry of Health.

Dr. Hamoud Marzuq Alrougi is a Saudi physician and public health professional affiliated with the Ministry of Health in Saudi Arabia. He is associated with the Saudi Field Epidemiology Training Program (FETP), where he has contributed to national efforts in public health surveillance and chemical safety. Dr. Alrougi’s work focuses on the prevention and investigation of chemical and drug-related hazards, including poisonings and toxic exposures. He co-authored a study titled “Characteristic of Clorox Poisoning before and during the COVID-19 Pandemic, Saudi Arabia, 2019–2020,” which examined trends in household chemical poisonings and their impact on public health. Through his involvement in the FETP and related Ministry of Health programs, Dr. Alrougi has played a role in improving data collection, risk analysis, and response strategies for chemical safety incidents in the Kingdom. While detailed public information about his current official title is limited, he is recognized for his contributions to chemical and drug safety initiatives and his active participation in public health research and training within Saudi Arabia’s health system.

David Matas is a renowned international human rights lawyer based in Winnipeg, Manitoba, Canada. He is co-founder and member of the International Advisory Board of the International Coalition to End Transplant Abuse in China (ETAC). His work has been pivotal in exposing unethical practices in organ transplantation, particularly forced organ harvesting, which has profound implications for global public health, patient safety, and health system integrity. He has authored, co-authored, or co-edited twelve books on human rights, including “Bloody Harvest: The Killing of Falun Gong for their Organs�? and “State Organs: Transplant Abuse in China.�? His writings and advocacy emphasize the importance of ethical standards in health care, transparency in medical systems, and international cooperation to prevent abuse in medical practices. In recognition of his contributions to human rights and health care ethics, Mr. Matas was awarded the Order of Canada in 2008 and nominated for the Nobel Peace Prize in 2010.

Dr. Nasibeh Zanjirani Farahani, Ph.D., M.S., is an Assistant Professor of Medicine and Technical Success Manager at the Mayo Clinic Platform, United States. A systems engineer and translational AI researcher, she focuses on developing, evaluating, and implementing AI and machine learning solutions that enhance clinical decision-making, particularly in cardiovascular and emergency medicine. Her expertise spans predictive and generative AI, natural language processing, simulation modeling, and ethical AI governance, guided by a strong foundation in industrial engineering, operations research, and systems optimization. She contributes to national AI policy through the Coalition for Health AI (CHAI) and Mayo Clinic’s AI Steering Committee and advocates for fairness and inclusion in healthcare AI. Dr. Zanjirani Farahani earned her Ph.D. in Industrial and Systems Engineering (Operations Research) from the University of Missouri–Columbia (USA), M.S. in Industrial Engineering (Management Systems) from Amirkabir University of Technology (Tehran Polytechnic), and B.S. in Industrial Engineering (System Analysis) from Alzahra University (Iran).

Pamela Rowe, MA, CCC-SLP, is a highly accomplished Speech-Language Pathologist and Public Health Consultant with extensive experience in clinical leadership, healthcare innovation, and professional education. As the CEO and Clinical Director of a leading speech-language pathology practice, she has dedicated her career to advancing communication sciences, improving access to care, and promoting health equity across diverse populations. An engaging international keynote speaker and moderator, Pamela has led workshops and seminars on topics ranging from communication disorders and early intervention to healthcare leadership and public health policy. She also serves as a Grant and RFP Reviewer, contributing her expertise to programs that enhance healthcare delivery and community well-being. Currently pursuing dual graduate degrees in Doctor of Health Science (DHSc) and Master of Public Health (MPH), Pamela continues to integrate clinical excellence with evidence-based public health strategies. Her multidisciplinary perspective, leadership experience, and passion for empowering communities make her a respected voice in both clinical and public health spheres.

Prof. Calvin Earl Jefferson is an accomplished healthcare professional and educator with a strong background in health administration, radiologic technology, and leadership. He holds a Master of Business Administration (MBA), a Bachelor of Science in Health Administration (BSHA), and professional credentials in Radiologic Technology (RADT). Currently pursuing his Doctor of Health Science (DHSc), Prof. Jefferson’s academic and professional focus centers on advancing healthcare systems through leadership, innovation, and evidence-based practice. He has contributed to both academic and clinical settings, emphasizing the importance of quality patient care, professional development, and organizational excellence in healthcare delivery. Prof. Jefferson is committed to preparing future healthcare leaders and promoting public health initiatives that enhance community well-being and equitable access to care.

Dr. Anand Srivastava is the Chairman and Founder of the Global Institute of Stem Cell Therapy and Research (GIOSTAR), headquartered in San Diego, California, USA. A distinguished scientist and visionary leader in the field of stem cell research and regenerative medicine, Dr. Srivastava has over 30 years of experience in molecular biology, human embryonic stem cell research, and translational therapeutics. His pioneering work has been instrumental in advancing the development of stem cell–based therapies for the treatment of various degenerative and genetic disorders. Under his leadership, GIOSTAR has established cutting-edge research and clinical centers across the globe, dedicated to delivering innovative and ethical regenerative medicine solutions. Dr. Srivastava has authored numerous scientific publications and serves as an advocate for integrating stem cell science into mainstream medical practice. His contributions continue to shape the global landscape of regenerative medicine, bridging the gap between scientific innovation and patient care.

Dr. Hamoud Marzuq Alrougi is a Saudi physician and public health professional affiliated with the Ministry of Health in Saudi Arabia. He is associated with the Saudi Field Epidemiology Training Program (FETP), where he has contributed to national efforts in public health surveillance and chemical safety. Dr. Alrougi’s work focuses on the prevention and investigation of chemical and drug-related hazards, including poisonings and toxic exposures. He co-authored a study titled “Characteristic of Clorox Poisoning before and during the COVID-19 Pandemic, Saudi Arabia, 2019–2020,” which examined trends in household chemical poisonings and their impact on public health. Through his involvement in the FETP and related Ministry of Health programs, Dr. Alrougi has played a role in improving data collection, risk analysis, and response strategies for chemical safety incidents in the Kingdom. While detailed public information about his current official title is limited, he is recognized for his contributions to chemical and drug safety initiatives and his active participation in public health research and training within Saudi Arabia’s health system.

Zeinab (Eva) Deris Zayeri is a biomedical researcher with a Master’s degree in Human Genetics from Utrecht University in the Netherlands, where she is currently a guest researcher in the Department of Biology. With a strong background in biomedical sciences and bioinformatics, her work bridges molecular biology and computational genomics. Over the past decade, she has gained extensive experience in academic research, diagnostic laboratories, and hospitals, including at the Netherlands Cancer Institute. Her expertise spans next-generation sequencing (NGS), metagenomics, molecular genetics, epigenetics, and data-driven disease research, particularly in cancer, inflammation, and metabolic reprogramming. Zeinab has co-authored multiple peer-reviewed publications on topics such as neuroinflammation in COVID-19, the genetic basis of cardiovascular disease in diabetes, and epigenetic biomarkers in colorectal cancer. Combining wet-lab precision with computational insight, she is dedicated to advancing human genetics and biomedical science through integrative, data-driven research and scientific writing.

Dr. A. Khan is a distinguished researcher and faculty member at Sichuan Agricultural University, China, specializing in agricultural sciences and public health–related research. His work focuses on improving sustainable agricultural practices, advancing food safety, and exploring the intersection between agricultural systems and community health outcomes. Dr. Khan has authored multiple peer-reviewed publications and has collaborated on several international research projects aimed at strengthening food security and enhancing rural health development. He is known for his evidence-based approach, innovative methodologies, and strong commitment to advancing scientific knowledge. He actively participates in global conferences, contributes to professional networks, and supports capacity-building initiatives for young researchers in the field.

Dr. Yolanda Cabello is a leading professional in assisted reproduction, working as a Senior Clinical Embryologist, Scientific and Quality Consultant, and Professor. With over 20 years of experience, she holds a Ph.D. in Basic Medical Sciences, degrees in Biology and Psychology, and various Master's degrees. Currently affiliated with the IVF LIFE - CARE FERTILITY Group and serving as a Lead Auditor for GlobalGROUP, her career spans laboratory management, scientific directorship, and extensive research on sperm selection and pregnancy outcomes. Dr. Cabello is a recognized international speaker and an active contributor to professional societies and national health guidelines. Dr. Yolanda Cabello is a leading expert in assisted reproduction, combining over 20 years of experience as a Senior Clinical Embryologist, scientific consultant, and psychologist. She holds a Ph.D. in Basic Medical Sciences and currently serves with the IVF LIFE - CARE FERTILITY Group and as a Lead Auditor for GlobalGROUP. An active researcher, professor at the International University of Valencia, and international speaker, Dr. Cabello has published extensively and plays a key role in developing lab guidelines for the Spanish Ministry of Health.

Prof. Anthony R. Marin, RPh, MSPharm, is the Program Chair of the Bachelor of Science in Pharmacy at the Department of Pharmacy, School of Medical Laboratory Sciences, St. Dominic College of Asia, Philippines. A registered pharmacist with a Master of Science in Pharmacy, he is actively pursuing a PhD in Pharmacy by Research. His research focuses on drug discovery, herbal development, and pharmaceutical innovation, aiming to advance therapeutic solutions. As Program Chair, he oversees curriculum development, faculty coordination, and student engagement, while contributing to research initiatives within the department. Prof. Marin has been recognized for his outstanding contributions to pharmacy education and maintains an active presence in the academic and research community through publications and collaborations.

Peggy Hanna is a senior consultant specializing in strategic health communication, risk communication, and community engagement (RCCE), with more than 30 years’ experience, primarily across the Middle East and North Africa (MENA) region. She has advised and trained teams for WHO, UNICEF, World Bank, major INGOs, and academic institutions, focusing on social and behavior change (SBC), emergency RCCE, and capacity building. Peggy holds a Master’s in Health Education and an MBA in Health Services Management and works in Arabic, French, and English. She has contributed to RCCE initiatives and publications for WHO regional programs and frequently supports vaccine confidence and humanitarian communication efforts.

Ingrid Liliana Minotta is an Epidemiologist and Health Economist with extensive experience in public health research, health policy, and program implementation. She is currently associated with the Secretaría Distrital de Salud in Bogotá, Colombia, where she contributes to the development and evaluation of public health strategies aimed at improving population health outcomes and strengthening health systems. Ingrid holds academic affiliation with the Universidad del Valle (Colombia), where she has been involved in research and academic initiatives focused on epidemiology, health economics, social determinants of health, and disease prevention. Her work emphasizes evidence-based decision-making, cost-effectiveness analysis, and the evaluation of health interventions to support equitable and sustainable health outcomes. With a strong background in public sector health management, surveillance data analysis, and health program evaluation, Ingrid has played a key role in guiding policy planning and public health responses at the district level. Her professional interests include health system strengthening, healthcare access, health equity, and improving health service delivery in diverse populations. She continues to contribute to interdisciplinary collaborations, academic presentations, and public health innovation initiatives within Colombia and the broader Latin American region.

Rashid Akhtar is a Public Health Professional and Research Scientist currently serving as a Project Officer, contributing to evidence-based public health programs and implementation research. He holds a Master of Public Health (MPH) from the National Institute of Health and Family Welfare (NIHFW), New Delhi, where he strengthened his expertise in epidemiology, health program evaluation, and disease prevention strategies. Additionally, he has completed a Post Graduate Diploma in Rural Development (PGDRD) and has undertaken advanced coursework through Johns Hopkins University (JHU), which has further enhanced his global health perspective. Rashid has been involved in multiple public health initiatives focusing on community health, maternal and child health, infectious disease surveillance, and strengthening primary health systems. His work revolves around designing and supporting research studies, data analysis, monitoring & evaluation of health interventions, and coordinating with stakeholders at various levels for effective program implementation. With a strong foundation in research methodology and field program management, Rashid aims to improve health outcomes in underserved populations through innovative and sustainable public health solutions. He continues to engage in collaborative research, public health capacity-building, and evidence-driven policy development.